Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dice Therapeutics Inc
(NQ:
DICE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 8, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dice Therapeutics Inc
< Previous
1
2
3
Next >
Recap: DICE Therapeutics Q1 Earnings
May 11, 2023
Via
Benzinga
Over $40M Bet On 89bio? Check Out These 3 Stocks Insiders Are Buying
March 31, 2023
Although US stocks closed higher on Thursday, there were a few notable insider trades.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
March 01, 2023
Via
Benzinga
These 3 Stocks Are Crushing the Market. Wall Street Thinks They Can Soar at Least 78% Higher.
November 18, 2022
The good times could keep on rolling for these big winners.
Via
The Motley Fool
Where DICE Therapeutics Stands With Analysts
November 15, 2022
Via
Benzinga
What Is Going on With DICE Therapeutics (DICE) Stock?
October 11, 2022
Shares of DICE stock are up an astounding 50% today on news of a positive clinical trial related to the Dice's psoriasis treatment.
Via
InvestorPlace
DICE Therapeutics Stock Doubles After Positive Data From Lead Psoriasis Candidate
October 11, 2022
Via
Benzinga
Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock
November 11, 2022
One indicator of where a company’s stock might be going in the future can be understood by what insiders may be thinking of the Company’s current stock price and near-term future outlook. Insiders are...
Via
Benzinga
Around $60 Million Bet On DICE Therapeutics? 3 Stocks Insiders Are Buying
October 20, 2022
Although US stocks closed lower on Wednesday, there were a few notable insider trades.
Via
Benzinga
Jim Cramer Says People Are Betting Against Stock Up 84% This Year: It Could Be An 'Up Big, Down Big Situation'
October 18, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Dice Therapeutics Inc (NASDAQ: DICE) as the company is "losing money hand over fist."
Via
Benzinga
Bear Market Hits New Lows, But Stocks Rebound After Hot CPI Inflation Report: Weekly Review
October 14, 2022
The major indexes tumbled to bear market lows after a hot CPI inflation report, but then roared back.
Via
Investor's Business Daily
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
October 12, 2022
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.
Via
Benzinga
Nasdaq Drops 150 Points; AZZ Shares Plummet
October 11, 2022
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 150 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 11, 2022
Gainers
Via
Benzinga
Why ForgeRock Shares Are Trading Higher By Over 49%, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
October 11, 2022
Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 140% to $0.3939.
Via
Benzinga
Dow Surges Over 100 Points; Crude Oil Down 2%
October 11, 2022
U.S. stocks pared some losses midway through trading, with the Dow Jones gaining more than 100 points on Tuesday.
Via
Benzinga
DICE Therapeutics, Amgen And Some Other Big Stocks Moving Higher On Tuesday
October 11, 2022
U.S. stocks traded mostly lower, with the Nasdaq dropping more than 100 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
US Stocks Open Lower, Dow Falls 100 Points
October 11, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Tuesday.
Via
Benzinga
Analyzing DICE Therapeutics's Short Interest
October 11, 2022
DICE Therapeutics's (NASDAQ:DICE) short percent of float has fallen 5.55% since its last report. The company recently reported that it has 4.93 million shares sold short, which is 17.52% of all regular...
Via
Benzinga
Nasdaq Bear Market: 2 Stocks Defying the Downturn
October 11, 2022
One of these companies is a leader in its niche, while the other wants to become one.
Via
The Motley Fool
Dice Therapeutics Surges To Record High As Psoriasis Pill Promises To Lead Its Class
October 11, 2022
The company is testing a potential pill to treat psoriasis.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 11, 2022
Gainers DICE Therapeutics (NASDAQ:DICE) stock moved upwards by 83.4% to $45.2 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.7 billion.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 22, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Looking Into DICE Therapeutics's Recent Short Interest
September 13, 2022
DICE Therapeutics's (NASDAQ:DICE) short percent of float has fallen 7.8% since its last report. The company recently reported that it has 5.22 million shares sold short, which...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 12, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...
Via
Benzinga
Dow Up Over 280 Points, Fourth-Straight Win In Sight
September 12, 2022
Stocks are firmly higher midday, with the Dow Jones Industrial Average last seen up over 280 points, while both the S&P 500 Index and Nasdaq Composite boast sizable gains of their own.
Via
Talk Markets
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
September 13, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
Via
Benzinga
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
September 12, 2022
Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
Via
Benzinga
Livent, Amgen And Some Other Big Stocks Moving Lower On Monday
September 12, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.